ERAP1 and neoplasm: Perturbation of APP in tumors may represent a strategy to elicit the presentation of both non-mutated tumor antigens with strong antitumor potential, as demonstrated by TEIPPs, and immunogenic epitopes usually destroyed by ERAP1 (53, 55, 57, 68, 69).